Ligand Pharmaceuticals
LGND
$70.46
Share price
-0.16%
Change (1 day)
-8.16%
Change (1 year)
Ligand Pharmaceuticals (LGND) Fails to deliver data
Key failure to deliver metrics for Ligand Pharmaceuticals:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.11 M
- Last 3 months FTD volume: $0.58 M
- Last year FTD volume: $3.53 M
Failures to deliver for Ligand Pharmaceuticals (LGND) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Ligand Pharmaceuticals (LGND) - since 2013
Volume in USD (price x number of shares), data since 2013Ligand Pharmaceuticals (LGND) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.58 M | -85.4% |
| 2023 | $4.01 M | -73.72% |
| 2022 | $15.27 M | -76.6% |
| 2021 | $65.29 M | -73.13% |
| 2020 | $0.24 B | 378.54% |
| 2019 | $50.77 M | -72.6% |
| 2018 | $0.18 B | 160.97% |
| 2017 | $71.02 M | 10.33% |
| 2016 | $64.37 M | 90.07% |
| 2015 | $33.86 M | 48.74% |
| 2014 | $22.76 M | 31.54% |
| 2013 | $17.3 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.14 B | $0.60 B | 🇺🇸 USA |
 Pfizer PFE | $31.87 M | $0.32 B | 🇺🇸 USA |
 Eli Lilly LLY | $50.92 M | $0.12 B | 🇺🇸 USA |
 Amgen AMGN | $65.7 M | $0.18 B | 🇺🇸 USA |
 Baxter BAX | $8.04 M | $0.18 B | 🇺🇸 USA |
 Merck MRK | $8.48 M | $0.18 B | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $0.19 B | $0.29 B | 🇺🇸 USA |
 GlaxoSmithKline GSK | $15.53 M | $26.02 M | 🇬🇧 UK |
 Spectrum Pharmaceuticals
SPPI | N/A | $0.44 M | 🇺🇸 USA |